Skip to main content
Screener/Healthcare/Biotechnology

ARCT — Arcturus Therapeutics Holdings Inc.

NASDAQ
$7.19-0.14 (-1.91%)
Micro CapUnder $10Healthcare
$5.85
$24.17
$7.00
$7.38
EPS (TTM)$-2.83
P/E Ratio-3.69
Dividend Yield—
Market Cap$235.9M
Volume142K
Prev Close$7.33
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$2.1M$1.9M$-0.950.0%93.7%
Q4 '25$3.1M-$29.1M$-1.0577.9%-943.8%
Q3 '25$17.2M-$13.4M$-0.4980.5%-78.4%
Q2 '25$24.5M-$9.2M$-0.34100.0%-37.5%
Q1 '25$29.4M-$14.1M$-0.52100.0%-47.9%
Q4 '24$21.0M-$30.0M$-1.11100.0%-142.9%
Q3 '24$38.8M-$6.9M$-0.26100.0%-17.8%
Q2 '24$46.0M-$17.2M$-0.64100.0%-37.4%
Get Your Daily Market Recap